Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.24.1.1.u2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]        
Cash equivalents $ 0   $ 0  
Trust Account $ 144,674,516      
Cash in the Trust Account     $ 142,069,535  
Ordinary shares subject to possible redemption 13,177,933   13,177,933  
Dissolution expenses $ 100,000      
Payment to redeeming shareholders 72,546,420      
Remeasurement of carrying value to redemption value 2,604,981   $ 9,974,792  
Offering costs as a reduction of temporary equity 29,576,119      
Gain on waiver of deferred underwriting fees       $ 342,975
Waiver of deferred underwriting fee payable       $ 6,655,361
Unrecognized tax benefits 0   $ 0  
Cash FDIC insured amount 250,000      
Share-Based Payment Arrangement, Expense 0      
Class ordinary shares     25,000  
Founder Shares [Member]        
Subsidiary, Sale of Stock [Line Items]        
Share-based compensation $ 0 $ 649,610    
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant 659,844      
Public And Private Warrants [Member]        
Subsidiary, Sale of Stock [Line Items]        
Offering costs $ 2,429,624      
IPO [Member]        
Subsidiary, Sale of Stock [Line Items]        
Class A ordinary shares sold 19,995,246      
Offering costs 32,005,743      
Underwriting discount amount 3,999,049      
Deferred underwriting fees 6,998,336      
Investor offering costs 18,958,165      
Other offering costs 2,050,193      
Purchase of aggregate shares $ 18,996,197